Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease

BACKGROUND: Automated tools for characterising dementia risk have the potential to aid in the diagnosis, prognosis, and treatment of Alzheimer’s disease (AD). Here, we examined a novel machine learning-based brain atrophy marker, the AD-resemblance atrophy index (AD-RAI), to assess its test-retest r...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qiling, Shi, Lin, Luo, Yishan, Wan, Chao, Malone, Ian B., Mok, Vincent C. T., Cole, James H., Anatürk, Melis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435378/
https://www.ncbi.nlm.nih.gov/pubmed/36062150
http://dx.doi.org/10.3389/fnagi.2022.932125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9435378/
https://www.ncbi.nlm.nih.gov/pubmed/36062150
http://dx.doi.org/10.3389/fnagi.2022.932125

Ejemplares similares